Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-06

FDA Approved: ALEVE PM — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental application for Aleve PM, adding the diphenhydramine HCl and naproxen sodium combination (Bayer HealthCare LLC) for the product’s la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALEVE PM (DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM)

Snippet

SUPPL AP for ALEVE PM (DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM)